San Diego-based Novalar Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company. The company’s initial product offering, NV-101 a local anesthetic reversal agent, was well tolerated and met the primary and secondary endpoints of two Phase 3 clinical studies and a Phase 2 pediatric study. The company is now focused on the execution of the commercialization plan for the US launch of the only local anesthetic reversal agent.
Novalar was sold to Novocol in Augist 2010.

Company Info
Country: USA
Industry:    Biotech
Sector: biotechnology
Status: Realized
Vehicle: Genevest

Company website

Endeavour Vision Team
Daniel Bertholet
Sven Lingjaerde
© Endeavour Vision SA 2006-2017 Terms & Conditions